Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8,204 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy outcomes of CDK4/6 inhibitors in combination with endocrine therapy treatment in hormone receptor-positive/HER2-negative advanced breast cancer according to PAM50 intrinsic subtype: Primary results of SOLTI-1801 CDK-PREDICT study.
Tolosa P, Pascual T, Martínez-Saez O, Hernando C, Servitja S, Fernández Abad M, Brasó-Maristany F, Sanfeliu E, Benitez Fuentes JD, Lema L, Ruano Y, García-Fructuoso I, Parrilla L, Rodríguez A, Roncero AM, Cobos MÁ, Sánchez-Bayona R, Alva M, Madariaga A, Villacampa G, Canes J, Salvador F, Sánchez-Belmonte A, Malumbres M, Prat A, Ciruelos E. Tolosa P, et al. Among authors: rodriguez a. Eur J Cancer. 2025 Jan 3:115219. doi: 10.1016/j.ejca.2024.115219. Online ahead of print. Eur J Cancer. 2025. PMID: 39779447
Adjuvant endocrine therapy with cyclin-dependent kinase 4/6 inhibitor, ribociclib, for localized hormone receptor-positive/HER2- breast cancer (LEADER).
Spring LM, Scarpetti L, Medford AJ, Niemierko A, Comander A, Mulvey T, Schnipper L, Isakoff SJ, Moy B, Wander SA, Shin J, Ephrem Z, Laposta AR, Denault E, Abraham E, Calistro G, Kalashnikova E, Rodriguez A, Liu MC, Aleshin A, Peppercorn J, Ellisen LW, Bardia A. Spring LM, et al. Among authors: rodriguez a. NPJ Breast Cancer. 2025 Jan 7;11(1):2. doi: 10.1038/s41523-024-00708-5. NPJ Breast Cancer. 2025. PMID: 39774684
Seasonal Influenza Vaccination Programs in the Americas: A Platform for Sustainable Life-Course Immunization and Its Role for Pandemic Preparedness and Response.
Nogareda F, Ghiselli M, Velandia-González M, de Mucio B, Jara J, Couto P, Rodriguez A, Rondy M, Vicari A, Ozturk MH, Goldin S, Vilajeliu A, Leidman E, Patel J, Carlton J, Fowlkes AL, Azziz-Baumgartner E, Salas Peraza D, Ropero AM. Nogareda F, et al. Among authors: rodriguez a. Vaccines (Basel). 2024 Dec 16;12(12):1415. doi: 10.3390/vaccines12121415. Vaccines (Basel). 2024. PMID: 39772075 Review.
Description of a New miRNA Signature for the Surgical Management of Thyroid Nodules.
Quiriny M, Rodrigues Vitόria J, Saiselet M, Dom G, De Saint Aubain N, Willemse E, Digonnet A, Dequanter D, Rodriguez A, Andry G, Detours V, Maenhaut C. Quiriny M, et al. Among authors: rodriguez a. Cancers (Basel). 2024 Dec 18;16(24):4214. doi: 10.3390/cancers16244214. Cancers (Basel). 2024. PMID: 39766113
[Consensus Recommendations for Lung Cancer Screening in Chile].
Suárez V F, Saavedra V MP, Roberti J, Boyeras I, Seijo M, Rodríguez AP, Silva F C, Verdugo B J, Sánchez T F, Solé P C, Valenzuela M R, Jalilie E A, García-Elorrio E. Suárez V F, et al. Among authors: rodriguez ap. Rev Med Chil. 2024 May;152(5):607-620. doi: 10.4067/s0034-98872024000500607. Rev Med Chil. 2024. PMID: 39760579 Free article. Spanish.
8,204 results